Kiniksa Pharmaceuticals Ltd (KNSA) — Free Cash Flow Generation Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $50.04 Million represents 1% of operating cash flow ($50.20 Million). See Kiniksa Pharmaceuticals Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kiniksa Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for Kiniksa Pharmaceuticals Ltd across 4 annual periods. Explore Kiniksa Pharmaceuticals Ltd (KNSA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Kiniksa Pharmaceuticals Ltd (2022–2025)
Year-by-year Free Cash Flow Generation Index for Kiniksa Pharmaceuticals Ltd. For the full company profile including market capitalisation, see market value of Kiniksa Pharmaceuticals Ltd.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▲ +0.0% |
| 2024 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▼ -0.1% |
| 2023 | 0.99x | $13.17 Million | $13.30 Million | $130.00K | ▲ +0.8% |
| 2022 | 0.98x | $5.70 Million | $5.81 Million | $105.00K | — |